Press release content from BusinessWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Two Day Seminar: Japan Regulatory Compliance Requirements for Life Science Products - ResearchAndMarkets.com

June 14, 2018

DUBLIN--(BUSINESS WIRE)--Jun 14, 2018--The “Japan Regulatory Compliance Requirements for Life Science Products” conference has been added to ResearchAndMarkets.com’s offering.

Course “Japan Regulatory Compliance Requirements for Life Science Products” has been pre-approved by RAPS as eligible for up to 12 credits towards a participant’s RAC recertification upon full completion.

This 2-Day seminar covers the details of the Regulatory Requirements for a wide-range of Life Science products in Japan: Pharmaceuticals, Biologics, Medical Devices and Combination Products. The syllabus also covers the change in Japan caused by the re-write of the Pharmaceutical Affairs Law [PAL] into the Pharmaceuticals & Medical Device Law [PMDL] and the country’s latest update to GMP requirements.

The information presented will help you gain a comprehensive understanding of the Regulatory Structure, Product Classification, Clinical Trial Requirements, Marketing Authorization Procedures, Variations Processing, License Renewals, GMP requirements and cultural working aspects within the Regulatory Environment in Japan.

It will prepare you for regulatory approval processes, Agency meetings, the complexities of running clinical studies, the importance of partner selection and also add the cultural knowledge needed for success in-country. The recent changes made by PMDA to be more sponsor and applicant-friendly, along with the impact this has had on dossier review times, will be shared. Real world experiences on actual interactions with the Agency, since these changes have been implemented, will also be discussed.

Course Objective:

The impact of the PAL to PMDL Law change to applicants Who can legally register Life Science products in Japan If you want to be the legal License holder, what will you need: establishment office & personnel type When will additional clinical trials be needed on products and on which ones Will Japan accept global, clinically-developed data How does a Japanese CTD submission differ from ICH requirements What is required to register a Medical Device in Japan Japan’s Medical Device classification procedures and regulatory pathways Can you expect a GMP inspection of your facility by PMDA staff; updates to GMP Regulation & Guidelines What are your post-marketing responsibilities as a License Holder How best to work with the Authorities from a Business and Cultural Aspect.

For more information about this conference visit https://www.researchandmarkets.com/research/g9q86t/two_day_seminar?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180614006231/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biotechnology



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/14/2018 04:40 PM/DISC: 06/14/2018 04:40 PM


All contents © copyright 2019 The Associated Press. All rights reserved.